Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA/USP meeting on Treatment INDs

Executive Summary

On May 3, FDA Associate Commissioner for Health Affairs Stuart Nightingale, MD, met with U.S. Pharmacopeial Executive Director Jerome Halperin and two members of the USP Board of Trustees to discuss how USP can help FDA to announce the availability of and information on Treatment IND drugs. USP agreed to publish the information in a new index to volume one of the USP DI, information compendium that goes to pharmacists, physicians and hospitals.
Advertisement
Advertisement
UsernamePublicRestriction

Register

PS017456

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel